1
|
Rozman A, Grabczak EM, George V, Marc Malovrh M, Novais Bastos H, Trojnar A, Graffen S, Tenda ED, Hardavella G. Interventional bronchoscopy in lung cancer treatment. Breathe (Sheff) 2024; 20:230201. [PMID: 39193456 PMCID: PMC11348910 DOI: 10.1183/20734735.0201-2023] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2024] [Accepted: 06/26/2024] [Indexed: 08/29/2024] Open
Abstract
Interventional bronchoscopy has seen significant advancements in recent decades, particularly in the context of lung cancer. This method has expanded not only diagnostic capabilities but also therapeutic options. In this article, we will outline various therapeutic approaches employed through either a rigid or flexible bronchoscope in multimodal lung cancer treatment. A pivotal focus lies in addressing central airway obstruction resulting from cancer. We will delve into the treatment of initial malignant changes in central airways and explore the rapidly evolving domain of early peripheral malignant lesions, increasingly discovered incidentally or through lung cancer screening programmes. A successful interventional bronchoscopic procedure not only alleviates severe symptoms but also enhances the patient's functional status, paving the way for subsequent multimodal treatments and thereby extending the possibilities for survival. Interventional bronchoscopy proves effective in treating initial cancerous changes in patients unsuitable for surgical or other aggressive treatments due to accompanying diseases. The key advantage of interventional bronchoscopy lies in its minimal invasiveness, effectiveness and favourable safety profile.
Collapse
Affiliation(s)
- Ales Rozman
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
- University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
| | - Elzbieta Magdalena Grabczak
- Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
| | - Vineeth George
- Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia
- Hunter Medical Research Institute, Newcastle, Australia
| | - Mateja Marc Malovrh
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
- University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
| | - Helder Novais Bastos
- Department of Pulmonology, Centro Hospitalar Universitário São João, Porto, Portugal
- Faculdade de Medicina da Universidade do Porto, Porto, Portugal
- i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
| | - Anna Trojnar
- Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
| | - Simon Graffen
- Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia
| | - Eric Daniel Tenda
- Dr. Cipto Mangunkusumo National General Hospital, Artificial Intelligence and Digital Health Research Group, The Indonesian Medical Education and Research Institute - Faculty of Medicine Universitas Indonesia (IMERI-FMUI), Jakarta, Indonesia
| | - Georgia Hardavella
- 4th–9th Department of Respiratory Medicine, ‘Sotiria’ Athens’ Chest Diseases Hospital, Athens, Greece
| |
Collapse
|
2
|
Commentary on “Intraluminal Brachytherapy for Malignant Endobronchial Tumors: An Update on Low-Dose Rate Versus High-Dose Rate Radiation Therapy”. Clin Lung Cancer 2001. [DOI: 10.1016/s1525-7304(11)70758-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|